SAN FRANCISCO, Feb. 26, 2026 /PRNewswire/ -- Higgsfield announces Cinema Studio 2.0, a major evolution of its flagship video tool and the go-to platform for creators and the world's top ad and film studios. This update redefines directorial control, giving creators the power to produce professional scenes up to 16 times more efficiently. With over 20 million active users, Higgsfield has become the infrastructure bridging the gap between independent creation and high-profile commercial contracts.
The platform has been adopted by leading production houses, including Vertex CGI and Secret Level, the AI-native studio behind campaigns for Coca-Cola, Will.i.am, and The Black Eyed Peas. Their Secret Level Academy trailer was built entirely on Higgsfield Cinema Studio. "There are plenty of AI platforms out there, but very few feel like they're made for filmmakers. Higgsfield does," says Jason Zada, an Emmy Award–winning filmmaker and Founder of Secret Level. "The innovation coming from them actually opens new creative doors, which is why we see them as one of the most exciting and original platforms in the space."
Through the Higgsfield Creators community hub, users showcase their portfolios to secure high-profile projects with top-tier organizations, including NBA teams, major fashion and sportswear brands, and leading technology companies.
Karsten Winegeart, CEO and Director of Dime Labs, leverages Higgsfield to land professional sports contracts. "AI first truly clicked for me during a spec project I created around the 2025 NBA Finals," says Karsten. "Using AI alongside traditional filmmaking let us create shots that would've cost hundreds of thousands of dollars to produce practically... That was the lightbulb moment. I realized AI wasn't replacing filmmaking, it was removing limitations."
Co-developed by Higgsfield's internal team of award-winning directors and editors, Cinema Studio 2.0 ensures that every feature mirrors the logic and workflow of a real production. "Our goal is to remove the 'production tax' that keeps great stories from being told," says Alex Mashrabov, CEO of Higgsfield. "We are excited to see the wide adoption of Cinema Studio, which gives creators the professional-grade consistency required to land real-world commercial campaigns."
How Cinema Studio 2.0 Powers Cinematic AI Video
The new generation of Cinema Studio now centers around a comprehensive Director Panel, allowing creators to orchestrate every element of a scene with professional precision.
New capabilities in Cinema Studio 2.0 include:
The Director Panel: Creators can now take full control of the virtual set, utilizing a library of 6 professional camera bodies, 11 optical lenses, and over 15 distinct director movements to define the exact look and feel of the shot.
Grid Mode: The platform now renders up to 16 variations of a shot simultaneously for the price of a single generation. This workflow allows directors to audition multiple takes instantly, dramatically reducing the time and budget required to lock the perfect starting image.
Multishot Editor: This allows users to lock every shot in a sequence, edit scene flows, adjust speed, and set specific genres to dictate the pacing and style of the video.
3D Scene Creation: The platform now enables the creation of fully spatial 3D scenes, giving directors more depth and immersive control over their environments.
Character & Emotional Range: The update introduces advanced character controls, allowing users to select specific actors and bring them to life with real emotional range, ensuring performances feel authentic and reactive.
Full 4K Resolution: All outputs can now be rendered in Full 4K, ensuring that the cinematic quality holds up for professional broadcast and large-screen formats.
To learn more about Cinema Studio 2.0 visit: https://higgsfield.ai/blog/cinema-studio-guide
About Higgsfield
Higgsfield is an AI-native generative video platform built for professional creators, brands, agencies, and marketing teams producing high-fidelity videos at scale. The company develops its own generative video and image models and integrates leading third-party models such as OpenAI's Sora, Google's Veo and Nano Banana, Alibaba's WAN, Kuaishou's Kling, MiniMax, and others into a single, production-ready workflow, allowing teams to select the best model for each creative task without rebuilding pipelines.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Higgsfield Advances Its Creator-First Platform with Cinema Studio 2.0
|
SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ -- CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed journal. The study strengthens the scientific foundation of the ingredient and supports its positioning as a science-based inner beauty solution.
Growing Importance of Scientific Validation in the Inner Beauty Market
The global beauty and personal care market is rapidly shifting toward "Beauty from within" approaches that improve skin condition through internal health support. In particular, the gut-skin axis has emerged as a key biological pathway linking gut microbiota to skin health, driving increased research into probiotic and postbiotic-based ingestible skincare solutions.
At the same time, consumers increasingly seek objective and measurable evidence addressing visible skin concerns such as UV-induced photoaging, barrier impairment, dryness, roughness, and loss of elasticity. As a result, clinically validated biomarkers and instrumental assessments have become critical in substantiating functional ingredient claims.
CJ BIO's Science-Based Solution: BiomeNrich™ POST SZ075
BiomeNrich™ POST SZ075 is a postbiotic ingredient within CJ BIO's Condition-Specific biotics solution brand, BiomeNrich™. It is a 100% plant-based postbiotic produced by fermenting rice germ using Latilactobacillus sakei, a strain originally isolated from kimchi. The ingredient is positioned to support Sleep & Skin Health, developed based on the gut–skin axis concept for inner beauty and mental wellness applications.
The newly published study evaluated the ingredient's mechanisms of action in improving skin health and influencing skin-related biomarkers. Findings demonstrated significant modulation of key markers associated with barrier integrity, hydration, and wrinkle appearance, including reductions in wrinkle severity and transepidermal water loss (TEWL), alongside increases in skin elasticity and dermal density.
Dual-Action Efficacy of BiomeNrich™ POST SZ075 for Skin Health
A clinical study (n=111, 12 weeks, 500 mg/day) published in Food Science and Biotechnology (2025) confirms the dual functionality of BiomeNrich™ POST SZ075 in combating UV-induced wrinkles and enhancing hydration.
I. Skin wrinkle and roughness
Compared to the placebo, the test group showed significant resilience against UV-induced damage:
- 1,140% improvement in wrinkle parameters around the eyes.
- 614% increase in skin elasticity.
- 172% increase in dermal density
II. Skin hydration and Transepidermal Water Loss
The study also demonstrated improvements in hydration-related and barrier-related parameters:
- 1,872% decrease in Transepidermal Water Loss (TEWL)
- 497% improvement in skin roughness and 280% reduction in desquamation.
- 309% increase in skin moisture content.
Detailed research data on BiomeNrich™ POST SZ075 can be found in CJ BIO's Nutrition Insight article.
https://na2.hubs.ly/H03W1K20
Differentiation Through Integrated Evidence
CJ BIO established a multi-layered validation framework for BiomeNrich™ POST SZ075, encompassing in vitro, in vivo, and human clinical studies. This stepwise research design enables mechanistic verification alongside measurable clinical outcomes, strengthening scientific credibility. This integrated validation framework enables brand partners to reference both mechanistic insights and clinical findings when developing product concepts.
In addition to the published clinical study on skin health, CJ BIO has also conducted research exploring sleep-related benefits of BiomeNrich™ POST SZ075, supporting its potential relevance across multiple wellness applications. As a postbiotic ingredient, BiomeNrich™ POST SZ075 offers formulation stability advantages compared to live probiotics, which may facilitate broader product development possibilities.
CJ BIO stated, "This study provides scientific evidence that postbiotics can contribute to skin health. CJ BIO will continue expanding its portfolio of science-backed biotics and functional ingredients to deliver differentiated solutions in the inner beauty market."
About CJ BIO
CJ BIO is the biotechnology business unit of CJ CheilJedang, leveraging over 70 years of fermentation expertise to deliver functional ingredients and solutions for the food, taste, nutrition, and health industries. CJ BIO is committed to providing sustainable, science-validated bio-solutions that enhance quality of life for customers and consumers worldwide.
Contact Information
Media Inquiries:
CJ BIO
Email: cjbio_brand@cj.net
Website: https://na2.hubs.ly/H03W1JT0
SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ -- CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed journal. The study strengthens the scientific foundation of the ingredient and supports its positioning as a science-based inner beauty solution.
Growing Importance of Scientific Validation in the Inner Beauty Market
The global beauty and personal care market is rapidly shifting toward "Beauty from within" approaches that improve skin condition through internal health support. In particular, the gut-skin axis has emerged as a key biological pathway linking gut microbiota to skin health, driving increased research into probiotic and postbiotic-based ingestible skincare solutions.
At the same time, consumers increasingly seek objective and measurable evidence addressing visible skin concerns such as UV-induced photoaging, barrier impairment, dryness, roughness, and loss of elasticity. As a result, clinically validated biomarkers and instrumental assessments have become critical in substantiating functional ingredient claims.
CJ BIO's Science-Based Solution: BiomeNrich™ POST SZ075
BiomeNrich™ POST SZ075 is a postbiotic ingredient within CJ BIO's Condition-Specific biotics solution brand, BiomeNrich™. It is a 100% plant-based postbiotic produced by fermenting rice germ using Latilactobacillus sakei, a strain originally isolated from kimchi. The ingredient is positioned to support Sleep & Skin Health, developed based on the gut–skin axis concept for inner beauty and mental wellness applications.
The newly published study evaluated the ingredient's mechanisms of action in improving skin health and influencing skin-related biomarkers. Findings demonstrated significant modulation of key markers associated with barrier integrity, hydration, and wrinkle appearance, including reductions in wrinkle severity and transepidermal water loss (TEWL), alongside increases in skin elasticity and dermal density.
Dual-Action Efficacy of BiomeNrich™ POST SZ075 for Skin Health
A clinical study (n=111, 12 weeks, 500 mg/day) published in Food Science and Biotechnology (2025) confirms the dual functionality of BiomeNrich™ POST SZ075 in combating UV-induced wrinkles and enhancing hydration.
I. Skin wrinkle and roughness
Compared to the placebo, the test group showed significant resilience against UV-induced damage:
- 1,140% improvement in wrinkle parameters around the eyes.
- 614% increase in skin elasticity.
- 172% increase in dermal density
II. Skin hydration and Transepidermal Water Loss
The study also demonstrated improvements in hydration-related and barrier-related parameters:
- 1,872% decrease in Transepidermal Water Loss (TEWL)
- 497% improvement in skin roughness and 280% reduction in desquamation.
- 309% increase in skin moisture content.
Detailed research data on BiomeNrich™ POST SZ075 can be found in CJ BIO's Nutrition Insight article.
https://na2.hubs.ly/H03W1K20
Differentiation Through Integrated Evidence
CJ BIO established a multi-layered validation framework for BiomeNrich™ POST SZ075, encompassing in vitro, in vivo, and human clinical studies. This stepwise research design enables mechanistic verification alongside measurable clinical outcomes, strengthening scientific credibility. This integrated validation framework enables brand partners to reference both mechanistic insights and clinical findings when developing product concepts.
In addition to the published clinical study on skin health, CJ BIO has also conducted research exploring sleep-related benefits of BiomeNrich™ POST SZ075, supporting its potential relevance across multiple wellness applications. As a postbiotic ingredient, BiomeNrich™ POST SZ075 offers formulation stability advantages compared to live probiotics, which may facilitate broader product development possibilities.
CJ BIO stated, "This study provides scientific evidence that postbiotics can contribute to skin health. CJ BIO will continue expanding its portfolio of science-backed biotics and functional ingredients to deliver differentiated solutions in the inner beauty market."
About CJ BIO
CJ BIO is the biotechnology business unit of CJ CheilJedang, leveraging over 70 years of fermentation expertise to deliver functional ingredients and solutions for the food, taste, nutrition, and health industries. CJ BIO is committed to providing sustainable, science-validated bio-solutions that enhance quality of life for customers and consumers worldwide.
Contact Information
Media Inquiries:
CJ BIO
Email: cjbio_brand@cj.net
Website: https://na2.hubs.ly/H03W1JT0
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
CJ BIO Publishes Clinical Study on BiomeNrich™ POST SZ075, a Postbiotic Ingredient Demonstrating Skin Improvement Benefits
